COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
28/09/2026
Company announcement No. 50 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 39, 2026) Copenhagen, Denmark, September 28, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq [...]
PerfectServe Doubles Down on Innovation to Help Health Systems Define, Measure, and Achieve Operational Excellence
28/09/2026
Building on 30 years of healthcare operational experience, PerfectServe is investing in technologies that deliver immediate value while creating the foundation for connected operational intelligence. Summary Defining [...]
Advance OC’s 2026 ‘Future of Healthcare Conference’ Returns to Irvine on October 7 at Major Inflection Point in U.S. Healthcare
28/09/2026
Dr. Sachin Jain of SCAN to keynote annual summit hosted at the UCI Beall Center for Innovation which will convene clinicians, policymakers, and community leaders to reimagine care across the lifespan IRVINE, Calif., [...]
Guerbet : H1 2026 Results.
28/09/2026
H1 2026 Results Revenue of €379.2m, nearly stable (-0.1%) at CER 1 and like-for-like 2 , in line with the Group’s forecast for the full year EBITDA of €30.6m, in line with the Group’s forecast for the full year Restated [...]
Guerbet : Résultats semestriels 2026.
28/09/2026
Résultats semestriels 2026 Chiffre d’affaires de 379,2 M€, quasiment stable (-0,1%) à TCC 1 et périmètre comparable 2 , en ligne avec les anticipations du Groupe sur l’ensemble de l’exercice EBITDA à 30,6 M€ en ligne [...]
Maxim Hair Restoration Named Best Hair Transplant Center at the 2026 Arte of Beauty Awards
28/09/2026
New York–founded hair restoration leader honored among hundreds of entries from 30+ countries New York City, NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Maxim Hair Restoration , a 15-location organization that operates [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 39 - 2026
28/09/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 21 septembre au 22 septembre 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2026
28/09/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 21st September to 22nd September 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
28/09/2026
Déclaration de transactions sur actions propres Paris, France (28 septembre 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 28 avril 2026, EssilorLuxottica déclare que le 21 septembre [...]
EssilorLuxottica: Disclosure of transactions in own shares
28/09/2026
Disclosure of transactions in own shares Paris, France (September 28, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026, EssilorLuxottica declares that [...]
Children’s National receives $4 million gift for healing arts, nature and play
28/09/2026
This investment expands joyful patient experiences for kids across the Washington, D.C., region, supporting healing arts, a garden and a camp for patients. Washington, DC, Sept. 28, 2026 (GLOBE NEWSWIRE) -- A new $4 [...]
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
28/09/2026
Binding term sheet with PsyLabs provides Psyence BioMed’s Texas subsidiary with exclusive U.S. development, supply and distribution rights to PsyLabs’ pharmaceutical-grade ibogaine, subject to a definitive agreement NEW [...]
BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer
28/09/2026
Preclinical data demonstrate prolonged KRAS target engagement and potent antitumor activity across multiple KRAS-mutant cancer models, supporting the continued advancement of BH-501284 toward an IND submission in Q1 [...]
BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team
28/09/2026
New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray Brands ELLON, Scotland and LONDON, Sept. 28, 2026 (GLOBE NEWSWIRE [...]
Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine
28/09/2026
– Pooled analysis of five clinical trials found no clinical or subclinical evidence of cardiotoxicity at cumulative doses exceeding traditional anthracycline limits – Independent Cleveland Clinic cardio-oncology [...]
Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate
28/09/2026
– ARV-6723 is an investigational, oral PROTAC designed to degrade HPK1, a negative regulator of immune activation, in advanced solid tumors – NEW HAVEN, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: [...]
Pharmazz Completes Enrollment in 160-Patient Phase 4 Trial of Sovateltide in Acute Ischemic Stroke
28/09/2026
Enrollment completed in the double-blind, placebo-controlled Phase 4 study ( NCT05955326 ) of sovateltide (Tycamzzi®), with final study data expected in Q1 2027 Five sovateltide abstracts accepted at World Stroke [...]
Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer
28/09/2026
- Stable or increased weight was twice as common among pancreatic cancer patients in the atebimetinib + mGnP study, compared to those in a benchmark study - - Patients with stable or increased weight at three months had [...]
Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer
28/09/2026
Dr. Houvras brings over two decades of executive leadership across premier industry and academic research institutions in clinical development, translational medicine and immuno-oncology WALTHAM, Mass., Sept. 28, 2026 ( [...]

Pages